Ariane V. Scarlatelli Macedo (@md_arianemacedo) 's Twitter Profile
Ariane V. Scarlatelli Macedo

@md_arianemacedo

Wife,Mom of 3 and a Belgian Malinois K9. Cardiologist, MHS, PhD. Prof. Med at Santa Casa SP. VP @SBTH_BSTH. Certified in Cardio-Oncology by @ICOSociety

ID: 2873036469

linkhttp://www.wihc.online calendar_today11-11-2014 23:09:04

2,2K Tweet

1,1K Followers

1,1K Following

JACC Journals (@jaccjournals) 's Twitter Profile Photo

#JACCCardioOnc EiC Dr. Bonnie Ky The Penn Thalheimer Center for Cardio-Oncology on next steps regarding SARAH trial, #AHA24: 🔹Advance precision medicine 🔹Identify high-risk populations who benefit from cardioprotection 🔹Develop rigorous consensus definitions of clinically relevant endpoints 🔹Define impact

#JACCCardioOnc EiC Dr. Bonnie Ky <a href="/PennThalheimer/">The Penn Thalheimer Center for Cardio-Oncology</a> on next steps regarding SARAH trial, #AHA24:
🔹Advance precision medicine
🔹Identify high-risk populations who benefit from cardioprotection
🔹Develop rigorous consensus definitions of clinically relevant endpoints
🔹Define impact
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Sacubitril/valsartan was tied to a lower risk cardiotoxicity compared with placebo among high-risk #cancer patients being treated with #anthracycline #chemotherapy agents, based on findings from the SARAH trial presented at #AHA24. bit.ly/4fTloRT #CardioOnc

Sacubitril/valsartan was tied to a lower risk cardiotoxicity compared with placebo among high-risk #cancer patients being treated with #anthracycline #chemotherapy agents, based on findings from the SARAH trial presented at #AHA24. bit.ly/4fTloRT #CardioOnc
Ariane V. Scarlatelli Macedo (@md_arianemacedo) 's Twitter Profile Photo

Today at the 3rd International Congress of SBTH Sociedade Brasileira de Trombose e Hemostasia in Brazil, Dr. Alex Spyropoulos Alex Spyropoulos shared cutting-edge insights on TEV prophylaxis . From mechanical to pharmacological strategies, his talk emphasized safety and prevention in clinical practice. #BSTH2024 ISTH

Today at the 3rd International Congress of <a href="/SBTH_BSTH/">SBTH Sociedade Brasileira de Trombose e Hemostasia</a> in Brazil, Dr. Alex Spyropoulos <a href="/AlexSpyropoul/">Alex Spyropoulos</a> shared cutting-edge insights on TEV prophylaxis . From mechanical to pharmacological strategies, his talk emphasized safety and prevention in clinical practice. #BSTH2024 <a href="/isth/">ISTH</a>
Lakeshia Cousin, PhD, APRN (@lakeshia_aprn) 's Twitter Profile Photo

Excited for the upcoming release of the following 📕 under visionary editor Sherry-Ann Brown, MD, PhD, FACC, FAHA Honored to lead Chapter 40: Health Equity in Cardio-Oncology with Arnethea L. Sutton, PhD Enat Arega, Timiya S. Nolan, PhD, APRN-CNP, FAAN and Eric H Yang, MD Pre-order: shop.elsevier.com/books/innovati…

Excited for the upcoming release of the following 📕 under visionary editor <a href="/drbrowncares/">Sherry-Ann Brown, MD, PhD, FACC, FAHA</a> 
Honored to lead Chapter 40: Health Equity in Cardio-Oncology with <a href="/NeNe_LaShaun/">Arnethea L. Sutton, PhD</a> Enat Arega, <a href="/TSNolanPhD/">Timiya S. Nolan, PhD, APRN-CNP, FAAN</a> and <a href="/datsunian/">Eric H Yang, MD</a> Pre-order: shop.elsevier.com/books/innovati…
Salim S. Hayek, MD (@salimhayek) 's Twitter Profile Photo

From 1999-2020, CVD mortality in US breast cancer patients declined significantly (-4.3% annually), but disparities persist: Black patients & rural regions face higher rates. Hypertensive diseases and arrhythmias show no improvement. #CardioOncology bit.ly/4iFZHHd

National Cancer Institute (@thenci) 's Twitter Profile Photo

Cancer survivors are growing in number. In the US, nearly half of survivors have lived 10 or more years after diagnosis, while 19% have lived 20 or more years. The prevalence of long-term survivors is expected to increase through 2040. go.nih.gov/rOUbZJD #CancerSurvivorship

Cancer survivors are growing in number. In the US, nearly half of survivors have lived 10 or more years after diagnosis, while 19% have lived 20 or more years. The prevalence of long-term survivors is expected to increase through 2040. go.nih.gov/rOUbZJD #CancerSurvivorship
European Society of Cardiology (@escardio) 's Twitter Profile Photo

🌍 Today, on #WorldCancerDay, we are proud to highlight our collaboration with key organisations in the cardio-oncology field. 🫀 As we continue to advance research and innovation in cardio-oncology, we invite you to stay updated with the latest developments. Join us in

🌍 Today, on #WorldCancerDay, we are proud to highlight our collaboration with key organisations in the cardio-oncology field.

🫀 As we continue to advance research and innovation in cardio-oncology, we invite you to stay updated with the latest developments. 

Join us in
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Quality of care metrics for #CardioOnc practice: The need for standardization and improvement in the management of patients with cancer. Methodology proposed by the ACC/AHA: jacc.org/doi/10.1016/j.… #JACCCardioOnc #cvEcho

Quality of care metrics for #CardioOnc practice: The need for standardization and improvement in the management of patients with cancer. Methodology proposed by the ACC/AHA: jacc.org/doi/10.1016/j.…

#JACCCardioOnc #cvEcho
Ariane V. Scarlatelli Macedo (@md_arianemacedo) 's Twitter Profile Photo

Huge congrats to our dear colleague Prof. Suely Rezende, on receiving the 2025 ISTH ISTH Esteemed Career Award! A brilliant mind and a true inspiration in thrombosis and hemostasis. We’re so proud!@SBTH_BSTH Society on Thrombosis and Haemostasis, Inc. isth.org/news/698852/IS…

drtarsh (@drtarsh) 's Twitter Profile Photo

Join us in Florence for the inaugural ESC Cardio-Oncology Conference 2025! Explore #cardiooncology through breakthrough research and clinical cases. Gain actionable insights, collaborate across cardiology and oncology, and network with experts. Secure your spot to shape heart

Join us in Florence for the inaugural ESC Cardio-Oncology Conference 2025! Explore #cardiooncology through breakthrough research and clinical cases. Gain actionable insights, collaborate across cardiology and oncology, and network with experts. Secure your spot to shape heart